Gritstone bio, Inc.Gritstone bio, Inc.Gritstone bio, Inc.

Gritstone bio, Inc.

No trades
See on Supercharts
Market capitalization
‪89.49 M‬USD
−1.2528USD
‪−138.49 M‬USD
‪1.33 M‬USD
‪97.27 M‬
Beta (1Y)
2.35

About Gritstone bio, Inc.

CEO
Andrew R. Allen
Headquarters
Emeryville
Employees (FY)
231
Founded
2015
ISIN
US39868T1051
FIGI
BBG00B8N2C16
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GRTS is 0.8411 USD — it has decreased by 8.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Gritstone bio, Inc. stocks are traded under the ticker GRTS.
Gritstone bio, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Gritstone bio, Inc. has a max estimate of 10.0000 USD and a min estimate of 3.0000 USD.
GRTS earnings for the last quarter are −0.33 USD whereas the estimation was −0.34 USD which accounts for 3.06% surprise. Estimated earnings for the next quarter are −0.33 USD. See more details about Gritstone bio, Inc. earnings.
Gritstone bio, Inc. revenue for the last quarter amounts to ‪1.57 M‬ USD despite the estimated figure of ‪1.89 M‬ USD. In the next quarter revenue is expected to reach ‪5.11 M‬ USD.
Yes, you can track Gritstone bio, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, GRTS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gritstone bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GRTS reached its all-time high on Jan 20, 2021 with the price of 35.2000 USD, and its all-time low was 0.8280 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 14, 2024, the company has 231.00 employees. See our rating of the largest employees — is Gritstone bio, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Gritstone bio, Inc. EBITDA is ‪−140.29 M‬ USD, and current EBITDA margin is ‪−11.05 K‬%. See more stats in Gritstone bio, Inc. financial statements.